[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Yan et al., 2020 - Google Patents

T cell-intrinsic IRF5 regulates T cell signaling, migration, and differentiation and promotes intestinal inflammation

Yan et al., 2020

View HTML @Full View
Document ID
16499571286376786417
Author
Yan J
Pandey S
Barnes B
Turner J
Abraham C
Publication year
Publication venue
Cell reports

External Links

Snippet

IRF5 polymorphisms are associated with multiple immune-mediated diseases, including ulcerative colitis. IRF5 contributions are attributed to its role in myeloid lineages. How T cell- intrinsic IRF5 contributes to inflammatory outcomes is not well understood. We identify a …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Yan et al. T cell-intrinsic IRF5 regulates T cell signaling, migration, and differentiation and promotes intestinal inflammation
Cook et al. Transcription factor Bhlhe40 in immunity and autoimmunity
Angiari et al. Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity
Wing et al. Control of germinal center responses by T-follicular regulatory cells
Meng et al. Double-negative T cells remarkably promote neuroinflammation after ischemic stroke
Hepworth et al. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4+ T cells
Tu et al. T cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation
Willinger Metabolic control of innate lymphoid cell migration
Domeier et al. B-cell-intrinsic type 1 interferon signaling is crucial for loss of tolerance and the development of autoreactive B cells
Talebi et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis
Rao et al. Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs
Lykken et al. Regulatory B10 cell development and function
Facciotti et al. Evidence for a pathogenic role of extrafollicular, IL-10–producing CCR6+ B helper T cells in systemic lupus erythematosus
Jacquemin et al. OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response
Locke et al. IL-13–regulated macrophage polarization during granuloma formation in an in vitro human sarcoidosis model
Staudt et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Iwata et al. ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastoma
Ghorbani et al. MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune neuroinflammation
Petermann et al. γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism
Geremia et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
Harada et al. The 3′ enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells
Fletcher et al. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Wang et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells
Miyahara et al. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
Wu et al. Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet’s disease